SRSF3 and glioblastoma: SRSF3 has been observed to exhibit high expression levels in a wide range of tumors, including breast cancer, cervical cancer, colorectal cancer, gastric cancer, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, non-small cell lung cancer, oral squamous cell carcinoma, ovarian cancer, and retinoblastoma [203, 207–225].